Canadian Journal of Cardiology · 2014 · 18 citations · 18 references
Life SciencesCell BiologyImmunologyCell SignalingInnate ImmunitySignal TransductionAtherosclerosis PharmacotherapyEndothelial ActivationEndothelial DysfunctionInflammatory MediatorsInflammatory SignalingMacrophage BiologyAtherosclerosis Molecular MechanismsAtherosclerosis-associated MacrophagesAtherosclerotic Disease PreventionEukaryotic Elongation FactorsHematopoietic DysregulationHematopoietic MicroenvironmentInflammation In Cardiovascular DiseaseMacrophage Signaling Pathways
We tested whether loss of eukaryotic elongation factor 2 kinase (eEF2K) activity in macrophages suppresses development of atherosclerosis by transplanting bone marrow from mice with mutant eEF2K into ldlr(-/-) mice. Sixteen weeks after high-fat diet feeding, mutant eEF2K hematopoietic chimeras had a dramatically reduced level of atherosclerotic plaque formation. M1-skewed macrophages from eEF2K knock-in mice have less tumour necrosis factor-α release and a lesser ability to induce expression of endothelial cell markers, providing a potential explanation for the role of eEF2K. Because eEF2K activity in cells of the hematopoietic compartment contributes to atherosclerosis development, drugs inhibiting eEF2K might have a beneficial effect in treatment of atherosclerosis.
18
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry, Megumi Adachi, E. D. Nosyreva et al. · Nature · 2011 · 1.9K citations
Rajendra K. Tangirala, Edward M. Rubin, Wulf Palinski · Journal of Lipid Research · 1995 · 516 citations · Full text
The combined role of P- and E-selectins in atherosclerosis.
Zhao Dong, Susan M. Chapman, Andrew Brown et al. · Journal of Clinical Investigation · 1998 · 453 citations · Full text